2017 - CIRTA

This page contains exclusive content for the member of the following sections: TTS, ITA

6- Medical and Surgical Rehabilitation

20.2 - Serial transverse enteroplasty procedure in the new era of gut rehabilitation

Presenter: Masato, Fujiki, Cleveland, United States
Authors: Masato Fujiki, Cassandra Pogatschnik, Lisa Moccia, Neha Parekh, Mohammed Osman, Koji Hashimoto, Ajai Khanna, Guilherme Costa, Kareem Abu-Elmagd

Serial transverse enteroplasty procedure in the new era of gut rehabilitation

Masato Fujiki1, Cassandra Pogatschnik1, Lisa Moccia1, Neha Parekh1, Mohammed Osman1, Koji Hashimoto1, Ajai Khanna1, Guilherme Costa1, Kareem Abu-Elmagd1.

1Center of Gut Rehabilitation and Transplantation, Cleveland Clinic, Cleveland, OH, United States

Introduction: With the recent evolution of gut rehabilitation, bowel lengthening has been increasingly utilized to restore nutritional autonomy in patients with chronic gut failure. This is the first largest single center experience with Serial Transverse Enteroplasty Procedure (STEP) for patients with different causes of gut failure including Crohn’s disease and intestinal recipients with short bowel syndrome (SBS).

Methods: Over the last 5 years, 40 patients received a total of 49 procedures at the Cleveland Clinic, Center of Gut Rehabilitation and Transplantation. Thirty-six patients were adults and 4 were children with a median age of 48 years (range; 2-79 years). Thirty-five (88%) patients required full total parenteral nutrition (TPN) with a mean duration of 21±28 months. The underlying pathology for SBS was vascular occlusion (n=22), surgical complication (n=9), Crohn’s disease (n=4), intestine transplant with SBS (n=1), and others (n=4). A mean length of residual small bowel was 70±42 cm. The colon was preserved in 37 (93%) with intact ileocecal valve in 9 (23%) and gut continuity in 13 (33%). The procedure was simultaneously performed with autologous gut reconstruction in 20 (50%) and as a second stage operation in the remaining 20 (50%) patients. The number of cuts ranged from 3 to 21. The STEP procedure was reproducible in 8 patients.

Results: Bowel lengthening was accomplished with a median increase of 20 cm (range:1-92 cm). There was a linear correlation between the length of the residual bowel and the increase in the bowel length after the STEP procedure. With a mean follow up of 14±11 months, 26 (74%) patients achieved full nutritional autonomy with discontinuation of TPN therapy. The remaining 10 patients continued to require partial TPN and adjunct GLP-2 therapy was initiated in 4. Predictors of successful outcomes include length of residual bowel, volume/caloric contents of TPN therapy, and presence of ileocecal valve. There was no significant impact of the underlying disease on achievement of nutritional autonomy.

Conclusions: STEP is an effective bowel lengthening procedure that should be offered to most of the SBS patients with gut failure. It is a valuable therapeutic option with patients with quiescent Crohn’s disease and intestinal recipients with short allograft syndrome and residual absorptive functions.

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory
This email address is being protected from spambots. You need JavaScript enabled to view it.


The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7